Prevalence of delayed gastric emptying in patients with gastroparesis‐like symptoms
Alimentary Pharmacology & Therapeutics · 2023-04 · 57 (7) · 773-782
DOI: 10.1111/apt.17330 ↗At a glance
Journal article in Alimentary Pharmacology & Therapeutics, published online on 2023-01-10. Written by I-Hsuan Huang and 8 co-authors. Institution: Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium. Major MEDLINE topics: Dyspepsia, Gastroparesis. Cited 23 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Takeda Pharmaceutical Company.
Abstract (original language)
Background
The European consensus defined gastroparesis as a condition characterised by delayed gastric emptying (GE) in the absence of mechanical obstruction, with a symptom pattern of predominant nausea and/or vomiting and overlapping postprandial distress syndrome (PDS). The distinction between patients with gastroparesis and those with functional dyspepsia (FD), another gastrointestinal condition characterised by predominant PDS or epigastric pain syndrome symptoms, is ongoing.
Aim
To investigate the extent that symptom patterns may differentiate gastroparesis from FD.
Methods
This retrospective study included 637 patients from Leuven University Hospital in 2006–2021 who had upper gastrointestinal symptoms, underwent a GE test, and completed the Dyspepsia Symptom Severity (DSS) questionnaire. Patients were identified as with gastroparesis‐like symptoms (GPLS; i.e ., moderate to severe nausea with moderate to severe PDS) or FD symptoms (not fitting GPLS). We excluded patients aged
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium.
- Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
- Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium.
- Global Evidence and Outcomes, Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA.
ORCID profiles: Bert Broeders, Tim Vanuytsel, Jan Tack
Funding
- Takeda Pharmaceutical Company
Cite
APA
Huang, I. H., Schol, J., Carbone, F., Chen, Y. J., Van den Houte, K., Balsiger, L. M., Broeders, B., Vanuytsel, T., & Tack, J. (2023). Prevalence of delayed gastric emptying in patients with gastroparesis‐like symptoms. Alimentary Pharmacology & Therapeutics, 57(7), 773-782. https://doi.org/10.1111/apt.17330
Vancouver
Huang IH, Schol J, Carbone F, Chen YJ, Van den Houte K, Balsiger LM, et al. Prevalence of delayed gastric emptying in patients with gastroparesis‐like symptoms. Alimentary Pharmacology & Therapeutics. 2023;57(7):773-782. doi:10.1111/apt.17330
BibTeX
@article{Huang2023,
author = {Huang, I-Hsuan and Schol, Jolien and Carbone, Florencia and Chen, Yaozhu J and Van den Houte, Karen and Balsiger, Lukas Michaja and Broeders, Bert and Vanuytsel, Tim and Tack, Jan},
title = {Prevalence of delayed gastric emptying in patients with gastroparesis‐like symptoms},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
volume = {57},
number = {7},
pages = {773--782},
doi = {10.1111/apt.17330}
}
EUVIMED